|
Name |
Isochromophilone III
|
Molecular Formula | C19H25ClO4 | |
IUPAC Name* |
(7R,8R,8aR)-5-chloro-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-7,8-dihydroxy-7-methyl-8,8a-dihydro-1H-isochromen-6-one
|
|
SMILES |
CC[C@H](C)/C=C(\C)/C=C/C1=CC2=C(C(=O)[C@]([C@@H]([C@H]2CO1)O)(C)O)Cl
|
|
InChI |
InChI=1S/C19H25ClO4/c1-5-11(2)8-12(3)6-7-13-9-14-15(10-24-13)17(21)19(4,23)18(22)16(14)20/h6-9,11,15,17,21,23H,5,10H2,1-4H3/b7-6+,12-8+/t11-,15-,17+,19+/m0/s1
|
|
InChIKey |
GJRRBURMULHWIH-WPHCLLNESA-N
|
|
Synonyms |
Isochromophilone III; 167173-89-9; (7R,8R,8aR)-5-chloro-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-7,8-dihydroxy-7-methyl-8,8a-dihydro-1H-isochromen-6-one; FO 32161; 6H-2-Benzopyran-6-one, 5-chloro-3-(3,5-dimethyl-1,3-heptadienyl)-1,7,8,8a-tetrahydro-7,8-dihydroxy-7-methyl; 6H-2-Benzopyran-6-one, 5-chloro-3-(3,5-dimethyl-1,3-heptadienyl)-1,7,8,8a-tetrahydro-7,8-dihydroxy-7-methyl-
|
|
CAS | 167173-89-9 | |
PubChem CID | 6450548 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 352.8 | ALogp: | 3.6 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 66.8 | Aromatic Rings: | 2 |
Heavy Atoms: | 24 | QED Weighted: | 0.75 |
Caco-2 Permeability: | -4.555 | MDCK Permeability: | 0.00002050 |
Pgp-inhibitor: | 0.006 | Pgp-substrate: | 0.733 |
Human Intestinal Absorption (HIA): | 0.011 | 20% Bioavailability (F20%): | 0.005 |
30% Bioavailability (F30%): | 0.005 |
Blood-Brain-Barrier Penetration (BBB): | 0.484 | Plasma Protein Binding (PPB): | 96.19% |
Volume Distribution (VD): | 2.739 | Fu: | 3.47% |
CYP1A2-inhibitor: | 0.283 | CYP1A2-substrate: | 0.211 |
CYP2C19-inhibitor: | 0.129 | CYP2C19-substrate: | 0.853 |
CYP2C9-inhibitor: | 0.1 | CYP2C9-substrate: | 0.17 |
CYP2D6-inhibitor: | 0.123 | CYP2D6-substrate: | 0.188 |
CYP3A4-inhibitor: | 0.635 | CYP3A4-substrate: | 0.311 |
Clearance (CL): | 6.374 | Half-life (T1/2): | 0.679 |
hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.128 |
Drug-inuced Liver Injury (DILI): | 0.972 | AMES Toxicity: | 0.613 |
Rat Oral Acute Toxicity: | 0.943 | Maximum Recommended Daily Dose: | 0.993 |
Skin Sensitization: | 0.945 | Carcinogencity: | 0.427 |
Eye Corrosion: | 0.868 | Eye Irritation: | 0.941 |
Respiratory Toxicity: | 0.973 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005431 | 0.819 | D0S7WX | 0.198 | ||||
ENC005432 | 0.781 | D06AEO | 0.195 | ||||
ENC001877 | 0.744 | D00DKK | 0.194 | ||||
ENC001871 | 0.744 | D0G3PI | 0.194 | ||||
ENC001884 | 0.703 | D02DGU | 0.194 | ||||
ENC005595 | 0.655 | D0C8HR | 0.192 | ||||
ENC003435 | 0.630 | D0H6VY | 0.190 | ||||
ENC001876 | 0.600 | D04ATM | 0.188 | ||||
ENC005596 | 0.581 | D0E9KA | 0.187 | ||||
ENC005433 | 0.573 | D0B1IP | 0.186 |